Data for M-CMV infected Nicotiana tabacum (Study ST000497)
(Analysis AN000764)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 |
---|---|---|---|---|---|---|---|
13-HODE + 9-HODE | 0.6115 | 1.2736 | 0.6856 | 0.9462 | 0.5129 | 3.9953 | 0.9174 |
1-linoleoylglycerol (1-monolinolein) | 0.8346 | 1.1640 | 0.6276 | 0.7023 | 0.9023 | 2.7560 | 0.8403 |
1-oleoylglycerophosphoglycerol* | 1.2764 | 1.0253 | 0.7951 | 0.5361 | 0.3327 | 1.2949 | 0.3576 |
1-palmitoylglycerophosphate | 0.6938 | 0.8037 | 0.6971 | 0.5893 | 0.3553 | 4.4883 | 0.9037 |
1-palmitoylglycerophosphoethanolamine | 0.8178 | 1.2583 | 0.6291 | 0.9272 | 0.3696 | 2.7324 | 1.1766 |
1-palmitoylglycerophosphoglycerol* | 1.0421 | 1.4400 | 0.6424 | 0.7053 | 0.2362 | 1.9766 | 0.7469 |
1-palmitoylglycerophosphoinositol* | 0.4277 | 0.6512 | 0.5731 | 0.4123 | 0.2774 | 6.6728 | 0.8469 |
2-hydroxydecanoate | 1.1021 | 0.7670 | 0.7519 | 1.5641 | 1.2352 | 0.6842 | 0.3852 |
2-hydroxypalmitate | 0.9319 | 0.9513 | 0.4874 | 0.5084 | 0.2987 | 3.6595 | 0.5034 |
2-isopropylmalate | 0.9270 | 2.3455 | 0.4552 | 1.2447 | 0.5485 | 1.4686 | 0.3753 |
2-myristoylglycerol (2-monomyristin) | 1.0175 | 1.1536 | 0.9415 | 0.6861 | 0.2906 | 1.1309 | 1.6920 |
3-butenylglucosinolate | 1.0000 | 0.9351 | 0.9351 | 1.3243 | 0.9351 | 0.9351 | 0.9351 |
5-oxoproline | 0.6259 | 1.2918 | 0.5699 | 1.3884 | 0.6926 | 2.1423 | 2.1596 |
9,10-epoxystearate | 0.7306 | 1.2409 | 0.6609 | 1.8413 | 0.6944 | 2.8123 | 0.3664 |
anthraniloyl-O-glucose | 1.1625 | 0.8375 | 0.8375 | 0.8375 | 0.8375 | 0.8375 | 0.8375 |
azelate (nonanedioate) | 0.9623 | 1.0393 | 0.9225 | 1.4871 | 1.1449 | 1.3006 | 0.3319 |
coumaroylquinate | 0.5177 | 0.8872 | 1.9969 | 0.6691 | 1.7089 | 2.5916 | 1.0400 |
cytidine | 0.8748 | 1.2217 | 1.0199 | 1.2113 | 0.8568 | 1.1652 | 1.2761 |
histidine | 0.3654 | 0.6320 | 0.6268 | 2.1986 | 0.7127 | 2.6803 | 2.9572 |
linoleate (18:2n6) | 1.0720 | 1.4653 | 0.5625 | 0.4654 | 0.4461 | 2.0743 | 0.5545 |
linolenate [alpha or gamma; (18:3n3 or 6)] | 1.1822 | 1.2713 | 0.5912 | 0.3466 | 0.4168 | 1.9561 | 0.3251 |
malonate (propanedioate) | 0.8869 | 1.1816 | 1.2290 | 1.0587 | 0.9301 | 1.2836 | 0.9959 |
phosphoethanolamine | 0.9346 | 0.4496 | 1.1877 | 1.2660 | 1.5071 | 0.6638 | 1.3180 |
pyridoxate | 0.8787 | 1.2610 | 0.9927 | 1.2111 | 1.3731 | 0.9950 | 0.8946 |
salidroside | 0.9632 | 0.9844 | 1.1734 | 0.9931 | 1.3033 | 1.0799 | 0.6868 |
sebacate (decanedioate) | 0.9281 | 1.1489 | 0.7662 | 1.5297 | 1.1694 | 1.3893 | 0.4280 |
sucrose | 1.0112 | 3.1413 | 0.1814 | 0.8516 | 0.3555 | 1.0379 | 0.3650 |
undecanedioate | 1.0023 | 0.9251 | 0.8813 | 1.1390 | 1.2671 | 1.4136 | 0.3598 |
uridine | 0.8309 | 1.3092 | 0.8713 | 1.3048 | 0.8789 | 1.2860 | 1.3645 |
valylleucine | 1.2920 | 1.0681 | 0.6796 | 0.6613 | 0.5189 | 0.6621 | 0.6579 |
Factors:
F1 | Treatment:control | Sample_description:- |
F2 | Treatment:Infected | Sample_description:complete green recovery |
F3 | Treatment:Infected | Sample_description:mosaic |
F4 | Treatment:Infected | Sample_description:patial green recovery |
F5 | Treatment:Infected | Sample_description:secondary mosaic |
F6 | Treatment:Infected | Sample_description:vein clearing |
F7 | Treatment:Infected | Sample_description:white chlorosis |